Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
Our pharmaceutical-grade Tirzepatide features 99% purity and is available in multiple packaging options to meet various research requirements. The product shows greater affinity for GIP receptors than GLP-1 receptors, producing enhanced hyperglycemia reduction effects.
We offer customization services including different vial sizes (2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 50mg) and private labeling options. All batches undergo rigorous quality control testing to ensure research-grade standards.
For researchers seeking tirzepatide costco alternatives, our direct-from-factory pricing provides significant savings on bulk orders while maintaining the highest quality standards. The product is strictly for research use only.